Role of platelets in thrombosis and hemostasis
- PMID: 8069774
- DOI: 10.1139/y94-043
Role of platelets in thrombosis and hemostasis
Abstract
Platelet aggregates, stabilized by fibrin, rapidly form hemostatic plugs when blood vessels are severed or arterial thrombi at sites of vessel injury, such as ruptured atherosclerotic plaques, or regions where blood flow is disturbed, such as at stenoses. These thrombi cause the thromboembolic complications of atherosclerosis: heart attacks, strokes, and peripheral vascular disease. Platelet adhesion to subendothelial components such as collagen activates signalling pathways that lead to thromboxane A2 formation and secretion of platelet granule contents, including ADP. Both these substances cause platelet aggregation, a process in which the integrin, glycoprotein IIb/IIIa, becomes a receptor for fibrinogen, which forms bridges between adjacent platelets. On the surface of stimulated platelets, coagulation is accelerated and thrombin is generated; it is a potent inducer of platelet aggregation and secretion and also causes fibrin to form around the aggregates, stabilizing them. There are receptors on the platelet surface for thrombin, thromboxane A2, collagen, ADP, platelet-activating factor, fibrinogen, von Willebrand factor, and other ligands. Agents that inhibit platelet aggregation and the signalling pathways that are activated by the various aggregating agents are under intensive investigation in many laboratories.
Similar articles
-
Disorders of platelet function.Dis Mon. 1992 Aug;38(8):577-631. Dis Mon. 1992. PMID: 1321709 Review.
-
The role of the platelet in the pathogenesis of atherothrombosis.Am J Cardiovasc Drugs. 2005;5(6):399-408. doi: 10.2165/00129784-200505060-00007. Am J Cardiovasc Drugs. 2005. PMID: 16259528 Review.
-
New targets for antithrombotic drugs.Am J Cardiovasc Drugs. 2002;2(4):227-35. doi: 10.2165/00129784-200202040-00002. Am J Cardiovasc Drugs. 2002. PMID: 14727968 Review.
-
Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):670-5. doi: 10.1161/01.ATV.0000200391.70818.a9. Epub 2005 Dec 15. Arterioscler Thromb Vasc Biol. 2006. PMID: 16357309
-
An overview of hemostasis.Vet Clin North Am Small Anim Pract. 1988 Jan;18(1):5-20. doi: 10.1016/s0195-5616(88)50003-7. Vet Clin North Am Small Anim Pract. 1988. PMID: 3282384 Review.
Cited by
-
A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings.Anesth Analg. 2016 Dec;123(6):1372-1379. doi: 10.1213/ANE.0000000000001413. Anesth Analg. 2016. PMID: 27224934 Free PMC article.
-
Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets.Blood. 2005 Nov 15;106(10):3410-4. doi: 10.1182/blood-2005-05-1933. Epub 2005 Jul 14. Blood. 2005. PMID: 16020504 Free PMC article.
-
Coagulation Dysfunction in Patients with Liver Cirrhosis and Splenomegaly and Its Countermeasures: A Retrospective Study of 1522 Patients.Dis Markers. 2023 Jun 7;2023:5560560. doi: 10.1155/2023/5560560. eCollection 2023. Dis Markers. 2023. PMID: 37325552 Free PMC article.
-
Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.Biochem J. 2002 Dec 1;368(Pt 2):535-43. doi: 10.1042/BJ20020226. Biochem J. 2002. PMID: 12215172 Free PMC article.
-
RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets.Biochem Pharmacol. 2009 Mar 1;77(5):835-44. doi: 10.1016/j.bcp.2008.11.017. Epub 2008 Nov 25. Biochem Pharmacol. 2009. PMID: 19073150 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
